Editor’s note: This story was updated at 5:30 p.m. Dec. 2 to include further detail on the vote, including statements from cannabis companies and CND delegates. In a historic vote, the United Nations Commission for Narcotic Drugs (CND) voted narrowly Dec. 2 to remove medicinal cannabis from Schedule IV... Read more

Licensed cannabis companies pay more than their fair share of taxes thanks to the business deduction restrictions placed on them by IRS Tax Code Section 280E. That tax law prevents cannabis producers from taking any deduction or credit unrelated to the cost of goods sold (COGS). With some well-thought-out... Read more

Updated: 11:13 a.m. Eastern Standard Time, Dec. 5 The U.S. House of Representatives has passed the Marijuana Opportunity Reinvestment and Expungement (MORE) Act, H.R. 3884, to remove cannabis from the U.S. Controlled Substances Act. It passed 228-164. “We applaud the House of Representatives for passing meaningful legislation aimed at... Read more